Approach to the patients with Graves'ophthalmopathy
10.3760/cma.j.issn.1000-6699.2016.01.017
- VernacularTitle:Graves眼病的临诊应对
- Author:
Wei ZHU
;
Lei YE
;
Qin JIAO
;
Shu WANG
;
Weiqing WANG
;
Guang NING
- Publication Type:Journal Article
- Keywords:
Graves'ophthalmopathy;
Immunosuppressive therapies;
Orbital irradiation;
Orbital decompression;
Rehabilitative surgery
- From:
Chinese Journal of Endocrinology and Metabolism
2016;(1):71-74
- CountryChina
- Language:Chinese
-
Abstract:
[Summary] Graves'ophthalmopathy ( GO) is the most common extrathyroidal manifestation of Graves disease ( GD) . It is an organ-specific autoimmune disorder. The estimated incidence of GO in the general population is 16 women and 3 men per 100,000 population every year. Approximately 3%-5% of patients with GO are exposed to the potential of losing their sight and requiring optimized medical intervention. For the clinicians it is helpful to assess the degree of activity and severity of GO;both are important in deciding whether a patient requires intervention and which type of intervention is indicated. These interventions include management of hyperthyroidism, measures to relieve local symptoms, immunosuppressive therapies for active moderate and severe GO, and finally rehabilitative surgery for inactive patients.
